Research > ETFs > ETF / ETP Commentary > 

3 Reasons Small-Caps Could Be the Sleeper Hit of 2026

Concentration risk, geopolitical risk, the return of inflationary pressure amid rising debt — it’s been a stressful year for investors already. Indeed, there are more negative stories than positive when it comes to investing. Still, there are opportunities, with small-caps potentially a sleeper hit that could surprise investors when they look back on their portfolios in January. Here are three reasons small-caps could make a big impact this year.Small-Caps May See Outsized Benefits From AI AdvancementsMarkets are concerned about the profitability of key names in the AI revolution, yes. However, perhaps the bigger risk is the concentration of the big tech names. Last year, the AI hyperscalers produced an outsized return in the S&P 500, and many investors rely heavily on those stocks in their core allocations.  While that may limit investor interest in adding more exposure to those huge names, there are other ways to benefit from the AI revolution. Small-caps in and outside of technology spaces will benefit from AI to operate with greater efficiency. AI agent help may even produce even bigger relative benefits than for the biggest companies, following the initial wave of large-cap adoption. See more: Amid AI Concentration Risk, TTEQ Spikes in Last Month “While the early stages of the artificial intelligence (AI) build‑out primarily favored large‑cap technology companies, we increasingly are seeing demand spill over to smaller firms,” wrote T. Rowe Price capital markets strategist Tim Murray in a recent analysis. “Some small‑cap companies are benefiting directly from AI‑related infrastructure spending, while others are seeing productivity gains from implementing AI within their own business processes,” he added. Small-Caps Are Seeing Faster Earnings GrowthMurray added that small-caps are also seeing faster earnings growth. Small-cap earnings rebounded sharply at the start of 2026, he explained, benefitting from a calming tariff outlook and fiscal benefits from the OBBA. “After nearly three years of poor relative performance, there is now clear evidence that U.S. small‑cap stocks are experiencing a renaissance,” he wrote. “Performance has improved and, more importantly, earnings growth has pivoted in a supportive direction.” What’s more, those firms could help drive a recovery from a second half downturn caused by rising energy prices. Smaller companies tend to lead recovery periods, potentially riding these existing trends in to the latter half of 2026. Rising Active ETFs Can Make an Especially Big Impact in Small-CapsActive ETFs provide a powerful toolset to get after small-cap upside, specifically. Active management can closely scrutinize smaller firms, applying a bottom-up approach that finds contenders rather than just those with the biggest market caps.  The T. Rowe Price Small-Mid Cap ETF (TMSL B+) charges 55 basis points to actively invest in small- and midcap stocks. The ETF, which will hit its key three-year ETF milestone this June, has returned 33.4% over the last twelve months, according to ETF Database data. At the same time, it has also added nearly a billion in net inflows over the last year.  Taken together, active ETFs like TMSL may make for intriguing options to get small-cap exposure this year. While headlines remain focused on stressors, smaller firms could prove a savvy investment with some rising trends boosting their prospects. For more news, information, and analysis, visit our Active ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.